Tocilizumab as an Adjuvant Therapy for Hemophagocytic Lymphohistiocytosis Associated With Visceral Leishmaniasis. (Q41433169)
Jump to navigation
Jump to search
scientific article published on 12 March 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tocilizumab as an Adjuvant Therapy for Hemophagocytic Lymphohistiocytosis Associated With Visceral Leishmaniasis. |
scientific article published on 12 March 2015 |
Statements
Tocilizumab as an Adjuvant Therapy for Hemophagocytic Lymphohistiocytosis Associated With Visceral Leishmaniasis (English)
Jose-Luis Callejas-Rubio
Sonia García-Rodríguez